Filter
833
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
84
New Publications
196
Language
Document type
No document type
369
Studies & Reports
183
Guidelines
149
Manuals
59
Strategic & Response Plan
41
Fact sheets
13
Training Material
8
Situation Updates
7
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Global
40
India
28
Kenya
27
Nigeria
22
Western and Central Europe
22
Ethiopia
20
South Africa
15
Uganda
11
Ukraine
11
Sierra Leone
10
Eastern Europe
10
Philippines
9
Tanzania
9
Rwanda
9
Ghana
8
Zimbabwe
8
Malawi
8
Namibia
8
Latin America and the Carribbean
8
Nepal
7
Liberia
6
Bangladesh
6
Eastern Europe and Central Asia
6
Africa
6
Zambia
5
Indonesia
5
Myanmar / Burma
5
South–East Asia Region
5
Senegal
4
Syria
4
Cambodia
4
Thailand
4
Botswana
4
West and Central Africa
4
Burkina Faso
3
Haiti
3
East and Southern Africa
3
Asia
3
Egypt
2
Sudan
2
Eswatini/ Swaziland
2
North Macedonia
2
Serbia
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
North America
2
Jamaica
2
Congo, Democratic Republic of
1
Mali
1
USA
1
Cameroon
1
Somalia
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
China
1
Mozambique
1
Papua New Guinea
1
Benin
1
Lesotho
1
Chile
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
260
Clinical Guidelines
90
Public Health
45
Pharmacy & Technologies
35
Key Resources
31
Women & Child Health
28
Capacity Building
7
Toolboxes
Pharmacy
114
AMR
104
COVID-19
61
TB
46
HIV
43
Rapid Response
42
Mental Health
33
Global Health Education
18
Planetary Health
18
NTDs
18
NCDs
18
Conflict
15
Caregiver
12
Health Financing Toolbox
10
Specific Hazards
7
Disability
6
Ebola
5
Polio
5
Refugee
5
Zika
2
Cholera
1
Natural Hazards
1
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
Southern Med Review (2009)2;1:2-6
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
PMPB/INS-GUIDE/02
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I
...
Technical Report
AIDS Medicines and diagnostics service
July 2015
Technical Report
AIDS Medicines and diagnostics service
September 2016
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro
...
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptio
...
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th
...
Fair global distribution of COVID-19 vaccines
recommended
MEDBOX Issue Brief no.9 ,1 Febr. 2021
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...